SAF-189s
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC (NCT06569420) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2021-12-31 |
Track SAF-189s automatically
Every clearance here is in the API, with alerts when new ones post.